InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Charles McWherter, President of R&D, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 12 open-market SEC Form 4 transactions: 3 purchases worth $180K and 9 sales worth $2.1M, reported from May 18, 23 to Jan 22, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 22, 25 | ETNB89bio, Inc. | BUY | 10.0K | $6.71 | $67K |
| Jan 21, 25 | ETNB89bio, Inc. | BUY | 5.0K | $6.55 | $33K |
| Dec 5, 24 | ETNB89bio, Inc. | BUY | 10.0K | $8.00 | $80K |
| Jan 19, 24 | CBAYCymaBay Therapeutics, Inc. | SELL | 8.3K | $23.68 | $197K |
| Dec 18, 23 | CBAYCymaBay Therapeutics, Inc. | SELL | 6.5K | $21.49 | $140K |
| Nov 17, 23 | CBAYCymaBay Therapeutics, Inc. | SELL | 11.3K | $18.28 | $207K |
| Oct 18, 23 | CBAYCymaBay Therapeutics, Inc. | SELL | 21.7K | $14.07 | $306K |
| Sep 18, 23 | CBAYCymaBay Therapeutics, Inc. | SELL | 21.7K | $16.22 | $353K |
| Aug 18, 23 | CBAYCymaBay Therapeutics, Inc. | SELL | 21.7K | $11.47 | $249K |
| Jul 18, 23 | CBAYCymaBay Therapeutics, Inc. | SELL | 21.7K | $11.43 | $249K |
| Jun 20, 23 | CBAYCymaBay Therapeutics, Inc. | SELL | 21.7K | $8.16 | $177K |
| May 18, 23 | CBAYCymaBay Therapeutics, Inc. | SELL | 21.7K | $9.08 | $197K |